Here is a list of stocks with an above 10% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Salesforce

18% sales growth and 9.67% return on equity

salesforce.com, inc.

Salesforce’s sales growth this year is anticipated to be 23.5% and 20.3% for next year.

Year-on-year quarterly revenue growth grew by 20.1%, now sitting on 20.29B for the twelve trailing months.

Salesforce’s sales growth for the next quarter is 18%. The company’s growth estimates for the current quarter and the next is 13.6% and 8.6%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.67%.

Salesforce’s Stock Yearly Top and Bottom Value

Salesforce’s stock is valued at $225.78 at 04:22 EST, way below its 52-week high of $284.50 and way higher than its 52-week low of $115.29.

Salesforce’s Moving Average

Salesforce’s value is under its 50-day moving average of $240.28 and higher than its 200-day moving average of $225.43.

Previous days news about Salesforce

Retailers navigate customer service in the last days of 'shipageddon'. According to The Wall Street Journal on Wed Dec 23, "Many deliveries are taking longer this holiday season as the coronavirus pandemic drives more people to rely on the internet to buy presents, a situation some retail observers have dubbed "Shipageddon." Salesforce’s Commerce Cloud reported nearly 45 million orders placed on its platform in the week commencing Cyber Monday, up 43% from the same week a year ago.", "Customers have in general been sympathetic to communicated delays, but still want their orders to arrive by Christmas at the end of a difficult year, said Lidiane Jones, the chief executive officer of Salesforce Commerce Cloud. "

Famed tech exec and investor April underwood has a brilliant new startup to save small retailers from Amazon. According to Business Insider on Wed Dec 23, "(Earlier this month, Slack was sold to Salesforce in a $27.7 billion megadeal.)"

16 customer relationship management firms taking on Salesforce and Microsoft that experts say to watch in 2021. According to Business Insider on Sun Dec 27, "Business Insider asked venture capitalists and analysts to name smaller CRM companies competing with behemoths like Salesforce and Microsoft. ", "Notably Salesforce has a similar line-up of products in its CRM platform."

2. Newmont Mining Corporation

47.8% sales growth and 10.48% return on equity

Newmont Corporation engages in the production and exploration of gold, copper, silver, zinc, and lead.

Newmont Mining Corporation’s sales growth this year is anticipated to be 18.2% and 22.7% for next year.

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 11.08B for the twelve trailing months.

Newmont Mining Corporation’s sales growth for the next quarter is 47.8%. The company’s growth estimates for the ongoing quarter and the next is 84% and 180%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.48%.

Newmont Mining Corporation’s Stock Yearly Top and Bottom Value

Newmont Mining Corporation’s stock is valued at $60.50 at 04:22 EST, way below its 52-week high of $72.22 and way higher than its 52-week low of $33.00.

Newmont Mining Corporation’s Moving Average

Newmont Mining Corporation’s value is under its 50-day moving average of $61.89 and below its 200-day moving average of $62.72.

3. Emergent Biosolutions, Inc.

104.4% sales growth and 14.57% return on equity

Emergent BioSolutions Inc., a life sciences company, focuses on the provision of specialty products for civilian and military populations that address accidental, deliberate, and naturally occurring public health threats (PHTs).

Emergent Biosolutions, Inc.’s sales growth this year is expected to be 38.3% and 22.4% for next year.

Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 1.33B for the twelve trailing months.

Emergent Biosolutions, Inc.’s sales growth for the next quarter is 104.4%. The company’s growth estimates for the ongoing quarter and the next is 80.3% and 18200%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.57%.

Emergent Biosolutions, Inc.’s Stock Yearly Top and Bottom Value

Emergent Biosolutions, Inc.’s stock is valued at $96.37 at 04:22 EST, way below its 52-week high of $137.61 and way above its 52-week low of $46.37.

Emergent Biosolutions, Inc.’s Moving Average

Emergent Biosolutions, Inc.’s value is way above its 50-day moving average of $86.38 and below its 200-day moving average of $96.48.

4. Ameris Bancorp

25% sales growth and 9.19% return on equity

Ameris Bancorp operates as the bank holding company for Ameris Bank that provides banking services to retail and commercial customers primarily in Georgia, Alabama, Florida, and South Carolina.

Ameris Bancorp’s sales growth this year is anticipated to be 57.1% and a negative 10.5% for next year.

Year-on-year quarterly revenue growth grew by 42.7%, now sitting on 895.64M for the twelve trailing months.

Ameris Bancorp’s sales growth for the next quarter is 25%. The company’s growth estimates for the ongoing quarter and the next is 20.8% and 246.4%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.19%.

Ameris Bancorp’s Stock Yearly Top and Bottom Value

Ameris Bancorp’s stock is valued at $36.67 at 04:22 EST, way below its 52-week high of $43.79 and way higher than its 52-week low of $17.12.

Ameris Bancorp’s Moving Average

Ameris Bancorp’s value is above its 50-day moving average of $34.89 and way above its 200-day moving average of $26.98.

5. AudioCodes Ltd.

10.5% sales growth and 7.23% return on equity

AudioCodes Ltd.

AudioCodes Ltd.’s sales growth this year is anticipated to be 9.9% and 10.4% for next year.

Year-on-year quarterly revenue growth grew by 10%, now sitting on 214.9M for the twelve trailing months.

AudioCodes Ltd.’s sales growth for the next quarter is 10.5%. The company’s growth estimates for the ongoing quarter and the next is 42.3% and 28%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.23%.

AudioCodes Ltd.’s Stock Yearly Top and Bottom Value

AudioCodes Ltd.’s stock is valued at $27.38 at 04:22 EST, way below its 52-week high of $44.94 and way above its 52-week low of $9.00.

AudioCodes Ltd.’s Moving Average

AudioCodes Ltd.’s worth is below its 50-day moving average of $27.73 and way under its 200-day moving average of $31.92.

6. Thor Industries, Inc.

63% sales growth and 12.55% return on equity

Thor Industries, Inc. designs, manufactures, and sells recreational vehicles (RVs), and related parts and accessories in the United States, Canada, and Europe.

Thor Industries, Inc.’s sales growth this year is expected to be 28.8% and 3.8% for next year.

Year-on-year quarterly revenue growth grew by 17.5%, now sitting on 8.55B for the twelve trailing months.

Thor Industries, Inc.’s sales growth for the next quarter is 63%. The company’s growth estimates for the current quarter and the next is 130.3% and 316.3%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.55%.

Thor Industries, Inc.’s Stock Yearly Top and Bottom Value

Thor Industries, Inc.’s stock is valued at $95.63 at 04:22 EST, way below its 52-week high of $121.33 and way higher than its 52-week low of $32.30.

Thor Industries, Inc.’s Moving Average

Thor Industries, Inc.’s value is higher than its 50-day moving average of $92.26 and under its 200-day moving average of $100.10.

7. Alamos Gold Inc Ordinary Shares

25.3% sales growth and 3.88% return on equity

Alamos Gold Inc., together with its subsidiaries, engages in the acquisition, exploration, development, and extraction of gold deposits in North America.

Alamos Gold Inc Ordinary Shares’s sales growth this year is anticipated to be 18.2% and 10.6% for next year.

Year-on-year quarterly revenue growth grew by 26.3%, now sitting on 707.5M for the twelve trailing months.

Alamos Gold Inc Ordinary Shares’s sales growth for the next quarter is 25.3%. The company’s growth estimates for the present quarter and the next is 600% and 25%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 3.88%.

Alamos Gold Inc Ordinary Shares’s Stock Yearly Top and Bottom Value

Alamos Gold Inc Ordinary Shares’s stock is valued at $9.25 at 04:22 EST, way under its 52-week high of $11.58 and way higher than its 52-week low of $3.34.

Alamos Gold Inc Ordinary Shares’s Moving Average

Alamos Gold Inc Ordinary Shares’s worth is above its 50-day moving average of $8.97 and under its 200-day moving average of $9.31.

8. MorphoSys AG

176.8% sales growth and 12.31% return on equity

MorphoSys AG, together with its subsidiaries, develops and commercializes antibodies and peptides for therapeutic applications in the United States.

MorphoSys AG’s sales growth this year is anticipated to be 362.3% and a negative 31.1% for next year.

Year-on-year quarterly revenue growth grew by 76.4%, now sitting on N/A for the twelve trailing months.

MorphoSys AG’s sales growth for the next quarter is 176.8%. The company’s growth estimates for the present quarter and the next is a negative 0% and 61.7%. The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.31%.

MorphoSys AG’s Stock Yearly Top and Bottom Value

MorphoSys AG’s stock is valued at $27.39 at 04:22 EST, way below its 52-week high of $37.96 and way higher than its 52-week low of $18.21.

MorphoSys AG’s Moving Average

MorphoSys AG’s value is above its 50-day moving average of $27.28 and under its 200-day moving average of $30.08.

LEAVE A REPLY

Please enter your comment!
Please enter your name here